Details for 2015815195

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATION UMFASSEND RIFAXIMIN UND CYCLOSPORIN ZUR VERWENDUNG DER BEHANDLUNG DES REIZDARMSYNDROMS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015815195

EP Publication Number

3160467

E-Number

1369038

Language

PCT Number

US15029083

Publication Date

03.05.2017 A

10.03.2021 B1

Registration Date

10.03.2021

AT Publication Date

15.03.2021

Application Date

04.05.2015

Registration Number

Priorities

30.06.2014

201462019388 P

11.08.2014

201462036097 P

IPC

A61K 31/437 20060101AFI20200611BHEP

Maximum Duration of Protection

04.05.2035

Owner

Salix Pharmaceuticals, Inc.400 Somerset Corporate Boulevard Bridgewater, NJ 08807US

Representative

No representatives present

Inventor

GOLDEN, Pam5 Fontana Court Durham, NC 27713US

BORTEY, Enoch225 Ocoee Falls Drive Chapel Hill, NC 27517US

FORBES, William1008 Heydon Court Raleigh, NC 27614US

PATERSON, Craig5 Marigold Place Durham, NC 27705US